A Falciformispora senegalensis grain model in Galleria mellonella larvae

Med Mycol. 2023 Aug 2;61(8):myad070. doi: 10.1093/mmy/myad070.

Abstract

Eumycetoma is a subcutaneous implantation mycosis often found in the foot. One of the hallmarks of eumycetoma is the formation of grains. These grains are either black or white, and the consistency and morphology differs per causative agent. The two most common causative agents of black-grain eumycetoma are Madurella mycetomatis and Falciformispora senegalensis. Since grains cannot be formed in vitro, in vivo models are needed to study grain formation. Here, we used the invertebrate Galleria mellonella to establish an in vivo grain model for F. senegalensis. Three different F. senegalensis strains were selected, and four different inocula were used to infect G. mellonella larvae, ranging from 0.04 mg/larvae to 10 mg/larvae. Larval survival was monitored for 10 days. Grain formation was studied macroscopically and histologically. The efficacy of antifungal therapy was determined for itraconazole, amphotericin B, and terbinafine. A concentration of 10 mg F. senegalensis per larva was lethal for the majority of the larvae within 10 days. At this inoculum, grains were formed within 24 h after infection. The grains produced in the larvae resembled those formed in human patients. Amphotericin B given at 1 mg/kg 4 h, 28 h, and 52 h after infection prolonged larval survival. No enhanced survival was noted for itraconazole or terbinafine. In conclusion, we developed a F. senegalensis grain model in G. mellonella larvae in which grains were formed that were similar to those formed in patients. This model can be used to monitor grain formation over time and study antifungal efficacy.

Plain language summary

Within eumycetoma lesions, the causative agents are embedded in grains. However, the grains differ per causative agent. In this study, we developed a grain model of Falciformispora senegalensis in the larvae of Galleria mellonella. This model can be used in the future to study the efficacy of novel antifungal agents.

MeSH terms

  • Amphotericin B / pharmacology
  • Animals
  • Antifungal Agents / pharmacology
  • Disease Models, Animal
  • Humans
  • Itraconazole
  • Larva / microbiology
  • Moths* / microbiology
  • Mycetoma* / microbiology
  • Mycetoma* / veterinary
  • Terbinafine

Substances

  • Antifungal Agents
  • Amphotericin B
  • Terbinafine
  • Itraconazole

Supplementary concepts

  • Falciformispora senegalensis